Abbott wins CE mark for new LAA closure device

With Amulet 360, Abbott aims to capture share from Boston Scientific in the market for devices that seal the heart’s left atrial appendage to reduce stroke risk.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top